Shandong Intco Medical Products Co Ltd (300677) - Net Assets
Based on the latest financial reports, Shandong Intco Medical Products Co Ltd (300677) has net assets worth CN¥18.57 Billion CNY (≈ $2.72 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥40.30 Billion ≈ $5.90 Billion USD) and total liabilities (CN¥21.73 Billion ≈ $3.18 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Shandong Intco Medical Products Co Ltd (300677) strategic asset index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥18.57 Billion |
| % of Total Assets | 46.08% |
| Annual Growth Rate | 49.6% |
| 5-Year Change | 15.19% |
| 10-Year Change | 3368.5% |
| Growth Volatility | 142.76 |
Shandong Intco Medical Products Co Ltd - Net Assets Trend (2013–2025)
This chart illustrates how Shandong Intco Medical Products Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see how much is Shandong Intco Medical Products Co Ltd worth.
Annual Net Assets for Shandong Intco Medical Products Co Ltd (2013–2025)
The table below shows the annual net assets of Shandong Intco Medical Products Co Ltd from 2013 to 2025. Also explore 300677 net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥18.57 Billion ≈ $2.72 Billion |
+5.03% |
| 2024-12-31 | CN¥17.68 Billion ≈ $2.59 Billion |
+8.51% |
| 2023-12-31 | CN¥16.29 Billion ≈ $2.38 Billion |
+1.53% |
| 2022-12-31 | CN¥16.05 Billion ≈ $2.35 Billion |
-0.46% |
| 2021-12-31 | CN¥16.12 Billion ≈ $2.36 Billion |
+70.75% |
| 2020-12-31 | CN¥9.44 Billion ≈ $1.38 Billion |
+528.77% |
| 2019-12-31 | CN¥1.50 Billion ≈ $219.76 Million |
+17.96% |
| 2018-12-31 | CN¥1.27 Billion ≈ $186.29 Million |
+17.06% |
| 2017-12-31 | CN¥1.09 Billion ≈ $159.14 Million |
+103.10% |
| 2016-12-31 | CN¥535.45 Million ≈ $78.35 Million |
+28.96% |
| 2015-12-31 | CN¥415.19 Million ≈ $60.76 Million |
+146.59% |
| 2014-12-31 | CN¥168.38 Million ≈ $24.64 Million |
+13.90% |
| 2013-12-31 | CN¥147.82 Million ≈ $21.63 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shandong Intco Medical Products Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1644792585450.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥16.44 Billion | 90.06% |
| Other Components | CN¥1.81 Billion | 9.94% |
| Total Equity | CN¥18.25 Billion | 100.00% |
Shandong Intco Medical Products Co Ltd Competitors by Market Cap
The table below lists competitors of Shandong Intco Medical Products Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Temenos Group AG
SW:TEMN
|
$4.71 Billion |
|
Galaxy Digital Holdings Ltd
NASDAQ:GLXY
|
$4.71 Billion |
|
ViTrox Corporation Bhd
KLSE:0097
|
$4.71 Billion |
|
360 ONE WAM LIMITED
NSE:360ONE
|
$4.71 Billion |
|
Eastern Bankshares Inc
NASDAQ:EBC
|
$4.71 Billion |
|
United Internet AG NA
XETRA:UTDI
|
$4.70 Billion |
|
Fortune Brands Innovations Inc.
NYSE:FBIN
|
$4.70 Billion |
|
SYSMEX CORP.UNSP.ADR 1/2
F:0YX0
|
$4.70 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shandong Intco Medical Products Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 17,404,080,149 to 18,253,839,363, a change of 849,759,214 (4.9%).
- Net income of 1,010,699,971 contributed positively to equity growth.
- Dividend payments of 422,168,604 reduced retained earnings.
- Other comprehensive income increased equity by 381,467.
- Other factors increased equity by 260,846,380.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥1.01 Billion | +5.54% |
| Dividends Paid | CN¥422.17 Million | -2.31% |
| Other Comprehensive Income | CN¥381.47K | +0.0% |
| Other Changes | CN¥260.85 Million | +1.43% |
| Total Change | CN¥- | 4.88% |
Book Value vs Market Value Analysis
This analysis compares Shandong Intco Medical Products Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.76x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 97.19x to 1.76x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥0.51 | CN¥49.14 | x |
| 2014-12-31 | CN¥0.58 | CN¥49.14 | x |
| 2015-12-31 | CN¥1.20 | CN¥49.14 | x |
| 2016-12-31 | CN¥1.36 | CN¥49.14 | x |
| 2017-12-31 | CN¥2.42 | CN¥49.14 | x |
| 2018-12-31 | CN¥2.42 | CN¥49.14 | x |
| 2019-12-31 | CN¥2.73 | CN¥49.14 | x |
| 2020-12-31 | CN¥25.35 | CN¥49.14 | x |
| 2021-12-31 | CN¥23.50 | CN¥49.14 | x |
| 2022-12-31 | CN¥23.87 | CN¥49.14 | x |
| 2023-12-31 | CN¥24.27 | CN¥49.14 | x |
| 2024-12-31 | CN¥26.84 | CN¥49.14 | x |
| 2025-12-31 | CN¥27.86 | CN¥49.14 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shandong Intco Medical Products Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.54%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.18%
- • Asset Turnover: 0.25x
- • Equity Multiplier: 2.20x
- Recent ROE (5.54%) is below the historical average (18.42%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 7.32% | 1.50% | 1.01x | 4.82x | CN¥-3.92 Million |
| 2014 | 18.92% | 3.60% | 1.35x | 3.90x | CN¥15.02 Million |
| 2015 | 15.47% | 6.43% | 1.32x | 1.82x | CN¥22.70 Million |
| 2016 | 16.07% | 7.27% | 1.02x | 2.17x | CN¥32.50 Million |
| 2017 | 13.34% | 8.29% | 1.06x | 1.52x | CN¥36.33 Million |
| 2018 | 14.09% | 9.48% | 0.78x | 1.90x | CN¥52.03 Million |
| 2019 | 12.07% | 8.56% | 0.70x | 2.03x | CN¥30.58 Million |
| 2020 | 74.99% | 50.64% | 1.07x | 1.38x | CN¥6.07 Billion |
| 2021 | 46.81% | 45.75% | 0.79x | 1.30x | CN¥5.84 Billion |
| 2022 | 3.98% | 9.51% | 0.31x | 1.36x | CN¥-951.56 Million |
| 2023 | 2.39% | 5.54% | 0.26x | 1.69x | CN¥-1.22 Billion |
| 2024 | 8.42% | 15.39% | 0.27x | 1.99x | CN¥-274.93 Million |
| 2025 | 5.54% | 10.18% | 0.25x | 2.20x | CN¥-814.68 Million |
Industry Comparison
This section compares Shandong Intco Medical Products Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,381,170,012
- Average return on equity (ROE) among peers: 13.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shandong Intco Medical Products Co Ltd (300677) | CN¥18.57 Billion | 7.32% | 1.17x | $4.71 Billion |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $858.96 Million | 5.81% | 3.43x | $498.13 Million |
| Blue Sail Medical Co Ltd (002382) | $8.46 Billion | 5.79% | 0.57x | $877.28 Million |
| Andon Health Co Ltd (002432) | $119.28 Million | 36.81% | 0.27x | $4.21 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $742.08 Million | 26.74% | 1.36x | $792.30 Million |
| Guangzhou Improve Med Instrument (300030) | $648.25 Million | 5.50% | 0.11x | $308.11 Million |
| QITIAN Technology Group Co Ltd (300061) | $1.31 Billion | -57.79% | 0.64x | $649.95 Million |
| Shanghai Tofflon Science Tech (300171) | $331.97 Million | 43.03% | 1.51x | $1.79 Billion |
| Truking Technology Ltd (300358) | $31.38 Million | 49.25% | 3.63x | $1.00 Billion |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $610.32 Million | 6.74% | 0.36x | $689.10 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $694.06 Million | 12.68% | 0.39x | $1.29 Billion |
About Shandong Intco Medical Products Co Ltd
Intco Medical Technology Co., Ltd. engages in the research and development, production, and marketing of medical consumables, rehabilitation equipment, and physiotherapy care for medical and elderly care institutions, household daily use, and other related industries in China and internationally. The company offers disposable gloves, gowns, apparel, face masks, diaper, pad, wipes, non-woven sundr… Read more